Evid Invest
Holders — by stockHoldings — by fund

GREAT POINT PARTNERS LLC

Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001281446

$418.5M

disclosed book value

43

positions

6.8%

largest position share

Positions, as of 2026-09-30

top 45 of 43 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held

#IssuerSharesValue% of book
1IBRXIMMUNITYBIO INCPUT3.0M$28.3M6.8%
2VERAVERA THERAPEUTICS INC808,717$26.1M6.2%
3VORVOR BIOPHARMA INC1.1M$21.5M5.1%
4AMLXAMYLYX PHARMACEUTICALS INC700,000$20.4M4.9%
5SGMTSAGIMET BIOSCIENCES INC2.0M$19.4M4.6%
6DFTXDEFINIUM THERAPEUTICS INC508,735$19.4M4.6%
7IONSIONIS PHARMACEUTICALS INC420,000$18.8M4.5%
8GMABGENMAB A/S525,000$18.7M4.5%
9SLGLSOL-GEL TECHNOLOGIES LTD239,159$17.8M4.2%
10ZURAZURA BIO LTD4.1M$17.0M4.1%
11LBRXLB PHARMACEUTICALS INC410,420$15.8M3.8%
12ABVXABIVAX SA155,000$15.3M3.7%
13ANNXANNEXON INC3.5M$14.8M3.5%
14BLTEBELITE BIO INC75,000$12.7M3%
15EPRXEUPRAXIA PHARMACEUTICALS INC1.2M$10.9M2.6%
16NKTRNEKTAR THERAPEUTICS175,000$10.6M2.5%
17MLTXMOONLAKE IMMUNOTHERAPEUTICS855,813$10.0M2.4%
18CLYMCLIMB BIO INC800,000$9.2M2.2%
19ABCLABCELLERA BIOLOGICS INC600,000$8.8M2.1%
20NGNENEUROGENE INC300,000$8.3M2%
21CMPSCOMPASS PATHWAYS PLC500,000$6.2M1.5%
22JATTJATT II ACQUISITION CORP500,000$5.6M1.3%
23IFRXINFLARX NV3.0M$5.5M1.3%
24RACCRESEARCH ALLIANCE CORP III504,891$5.5M1.3%
25DRUGBRIGHT MINDS BIOSCIENCES INC109,603$5.5M1.3%
26AMANAMANAT ACQUISITION CORP500,000$5.3M1.3%
27ALTALTIMMUNE INC1.7M$5.0M1.2%
28JTTTJATT III ACQUISITION CORP450,000$5.0M1.2%
29PHVSPHARVARIS N VPUT150,000$4.8M1.1%
30SCYXSCYNEXIS INC944,292$4.7M1.1%
31CGEMCULLINAN THERAPEUTICS INC300,000$4.6M1.1%
32CTNMCONTINEUM THERAPEUTICS INCCALL300,000$4.0M1%
33HELPCYBIN INC320,952$3.9M0.9%
34RZLTREZOLUTE INC951,809$3.9M0.9%
35IRDOPUS GENETICS INC776,881$3.8M0.9%
36ELVNENLIVEN THERAPEUTICS INC70,000$3.2M0.8%
37RLMDRELMADA THERAPEUTICS INC842,106$3.2M0.8%
38DBVTDBV TECHNOLOGIES S A250,000$2.9M0.7%
39EVMNEVOMMUNE INC325,000$2.7M0.6%
40CTNMCONTINEUM THERAPEUTICS INC186,183$2.5M0.6%
41ORKAORUKA THERAPEUTICS INC24,649$2.1M0.5%
42HUMAHUMACYTE INC3.8M$1.9M0.5%
43RNTXREIN THERAPEUTICS INC1.7M$1.3M0.3%
44RACDRESEARCH ALLIANCE CORP IV106,396$1.3M0.3%
45ANNXANNEXON INCCALL97,300$411,5790.1%

Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.